ArticleDiabetologia2007

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).

M Raikou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.